바이오-좀™ 기술, 스킨케어의 넥스트제네레이션
Hyper exosome technology, A new paradigm for skin generation
생명공학 30년 이상의 연구 성과
바이오-좀™은 피부 메커니즘에서 찾은
특허 받은 활성인자 컴플렉스입니다.
“30 Tears of Biotechnology Research Achievements”
Bio-Zome is a cultured product developed using proprietary growth factor stabilization technology.
Hyper-exosomes are present in the Wharton’s jelly stem cell culture medium.
체온을 견디는 열안정화 기술
Heat-Stable and Resilient to Body
Temperature
체온에 의한 성분 손상이 많았던
기존 제품들 문제점 개선
Solves the common issue of ingredient
degradation due to body heat,
ensuring product integrity and
effectiveness.
피부활성화의 이상적 포뮬라
Ideal formula for skin
revitalization
파이토액티좀™, 고안정성 성장인자 컴플렉스,
PDRN, HA 포함
Phytoactisome™, High Stability Growth
Factors Complex, Including PDRN, HA
실온보관 가능
Stable at Room
Temperature
성분 유지를 위한
별도 환경 조성 불필요
No special storage conditions are
required to maintain the product’s
effectiveness.
라보센이 전하는
근본적 피부 솔루션
Labossen Fundamental
Skin Solution
라보센은 30년 이상의 생명공학 연구 노하우를 바탕으로 탄생한 브랜드
입니다.
라보센 바이오-좀™ 스킨은 피부환경 개선을 위해 엄선된고품질의 핵심 성
분(파이토액티좀™, 특허 성장인자, HA, PDRN 등) 을이상적인 비율로 배
합하여 완성한 프리미엄 스킨케어 솔루션입니다.
라보센 바이오-좀™ 스킨의 특허 기술로 차별화 된 피부 솔루션을 경험해보세요.
Labossen is a brand created based on over 30 years of biotechnology research expertise.
Labossen Bio-Some Skin is a premium skincare complex that combines the ideal ratio of selected high-quality ingredients (Pytoactisome™, patented growth factors, HA, PDRN, etc.) to build a young skin environment.
Experience a different skin solution with the patented complex of Labossen Bio-Xome skin.
LABOSSEN
바이오좀 기술
LABOSSEN BIO-XOME
PRODUCTION TECHNOLOGY
01
파이토액티좀™
사용
PhytoactisomeTM are highly pure
and show long acting
activities.
Using Phytoactisome™
PhytoactisomeTM are highly pure
and show long acting
activities.
02
고활성, 고안정성
성장인자 컴플렉스 포뮬라
Growth factor complex is ideally
formulated to deliver optimum
skin care benefits.
High Stability & High Active
Growth Factor Complex
Formula
Growth factor complex is ideally
formulated to deliver optimum
skin care benefits.
03
고품질 바이오-좀™
Formulated with High-Quality
Bio-Xome™.
High-quality Bio-Xome™
Formulated with High-Quality
Bio-Xome™.
LABOSSEN PRODUCT TECHNOLOGY
고활성 고안정성 성장인자 기술
High-stability & High-Active Growth Factor Technology
이러한 문제점이 보완된,
LABOSSEN 고안정 & 고활성 성장인자
열안정화 특허 성장인자 기술로 상온 유통/보관 가능한 동결건조 바이오좀
도포 후 체온의 영향을 받지 않고 성분 유지
LABOSSEN High Stability
& High Active Growth Factors - Advanced
Freeze-dried biosomes can be distributed/stored at room temperature using patented heat-stabilized
growth factor technology after application. The ingredients are unaffected by body temperature.
공유결합을 통한 성장인자 안정화 기술
Through covalent bonds
High-Activity Growth Factor Technology -
Through covalent bonds
*성장인자란?
*What are Growth Factors?
세포증식, 상처치유, 세포분화를 자극하는 인체 내 자연 발생물질로
피부재생 촉진, 단, 나이가 들면서 인체 내 분비량 감소
These are naturally occurring substances within the human body that stimulate cell proliferation, wound healing,
and cell differentiation. They enhance skin regeneration and the body’s production of these factors decline with age.
피부세포 bFGF [라보센 / 일반] 비교 테스트 결과
피부 세포에 대한 라보센 bFGF, 일반 bFGF 테스트 결과, 라보센 bFGF의 ROS 감소를 확인할 수 있습니다.
Skin Cell bFGF (Labossen/Standard)
Comparative Test Results
Tests of Labossen bFGF and Standard bFGF on skin cells demonstrated that high-activity
bFGF effectively reduces Reactive Oxygen Species (ROS).
고안정 성장인자
관련 논문 / 특허
High Stability
Growth Factors
Related Papers
/ patent
관련논문
Related Papers
“Development of Stabilized Growth Factor-Loaded Hyaluronate– Collagen Dressing (HCD) matrix for impaired wound
healing”
Biomaterials Research (2016) 20:1-7
“Effects of structurally stabilized EGF and bFGF on wound healing in type I and type II diabetic mice” Acta
Biomaterialia
(2018) 40:325-334
“Development of stabilized dual growth factor-loaded hyaluronate collagen dressing matrix” Journal of Tissue
Engineering
(2021) 12:1-13
특허
patent
“Highly stabilized epidermal growth factor mutants” KP 10-1519118
“Highly stabilized epidermal growth factor mutants” USP 9102755
“Human basic fibroblast factor-2 mutants with high stability and use of the same” KP 10-1754272
“Human basic fibroblast factor-2 mutants with high stability and use of the same” KP 10-1778202
“Human fibroblast growth factor-2 mutants with increased stability, and use thereof” USP 11207257
“Human fibroblast growth factor-2 mutants with increased stability, and use thereof” JP 6665281
“Highly-stable mutant of basic fibroblast growth factors with modified N-terminal amino acid region, and uses
thereof”
KP 10-1891678
technical achievements
라보센 기술적 성과 및 인증서
Related Patents & Certifications
HOW TO USE
라보센 관리 주기
LABOSSEN Management cycle
기본 5회 프로토콜
Standard Five-Session Protocol
관리효과 유지를 위해 3-6개월 주기로 관리 권장
For sustained results, subsequent treatments are
recommended every three to six months.
샘플신청&문의
Inquiry